STATISTICAL ANALYSIS The analytical approach and power calculations have been published previously, 14 and the com- plete prespecified statistical analysis plan is avail- able with the protocol at NEJM.org. In brief, a formal interim analysis was originally planned when 75% of primary outcome events had oc- curred. However, during the conduct of the trial it became apparent that the interim analysis would occur close to the end of the trial. The executive committee therefore decided to remove the in- terim analysis from the protocol. We estimated that 681 primary outcome events would be needed to detect a 22% lower relative risk in the dapagliflozin group than in the placebo group (hazard ratio of 0.78), with 90% power using a two-sided alpha level of 0.05 and assuming an annual event rate for the primary outcome of 7.5% in the placebo group. A closed testing pro- cedure that included a prespecified hierarchical order of the primary and secondary outcomes was used to ensure control of type I error at a two-sided 0.05 level.
STATISTICAL ANALYSIS The analytical approach and power calculations have been published previously, 14 and the com- plete prespecified statistical analysis plan is avail- able with the protocol at NEJM.org. In brief, a formal interim analysis was originally planned when 75% of primary outcome events had oc- curred. However, during the conduct of the trial it became apparent that the interim analysis would occur close to the end of the trial. The executive committee therefore decided to remove the in- terim analysis from the protocol. We estimated that 681 primary outcome events would be needed to detect a 22% lower relative risk in the dapagliflozin group than in the placebo group (hazard ratio of 0.78), with 90% power using a two-sided alpha level of 0.05 and assuming an annual event rate for the primary outcome of 7.5% in the placebo group. A closed testing pro- cedure that included a prespecified hierarchical order of the primary and secondary outcomes was used to ensure control of type I error at a two-sided 0.05 level.
MATLAB: An Introduction with Applications
6th Edition
ISBN:9781119256830
Author:Amos Gilat
Publisher:Amos Gilat
Chapter1: Starting With Matlab
Section: Chapter Questions
Problem 1P
Related questions
Question
100%
I need help dissecting this (attached) in layman's terms.
Statistical Analysis-
The analytical approach and power calculations
have been published previously,14 and the complete
prespecified statistical analysis plan is available
with the protocol at NEJM.org. In brief, a
formal interim analysis was originally planned
when 75% of primary outcome events had occurred.
However, during the conduct of the trial it
became apparent that the interim analysis would
occur close to the end of the trial. The executive
committee therefore decided to remove the interim
analysis from the protocol. We estimated
that 681 primary outcome events would be
needed to detect a 22% lower relative risk in the
dapagliflozin group than in the placebo group
(hazard ratio of 0.78), with 90% power using a
two-sided alpha level of 0.05 and assuming an
annual
7.5% in the placebo group. A closed testing procedure
that included a prespecified hierarchical
order of the primary and secondary outcomes
was used to ensure control of type I error at a
two-sided 0.05 level.
Transcribed Image Text:STATISTICAL ANALYSIS
The analytical approach and power calculations
have been published previously, 14 and the com-
plete prespecified statistical analysis plan is avail-
able with the protocol at NEJM.org. In brief, a
formal interim analysis was originally planned
when 75% of primary outcome events had oc-
curred. However, during the conduct of the trial it
became apparent that the interim analysis would
occur close to the end of the trial. The executive
committee therefore decided to remove the in-
terim analysis from the protocol. We estimated
that 681 primary outcome events would be
needed to detect a 22% lower relative risk in the
dapagliflozin group than in the placebo group
(hazard ratio of 0.78), with 90% power using a
two-sided alpha level of 0.05 and assuming an
annual event rate for the primary outcome of
7.5% in the placebo group. A closed testing pro-
cedure that included a prespecified hierarchical
order of the primary and secondary outcomes
was used to ensure control of type I error at a
two-sided 0.05 level.
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Step by step
Solved in 2 steps
Recommended textbooks for you
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
Elementary Statistics: Picturing the World (7th E…
Statistics
ISBN:
9780134683416
Author:
Ron Larson, Betsy Farber
Publisher:
PEARSON
The Basic Practice of Statistics
Statistics
ISBN:
9781319042578
Author:
David S. Moore, William I. Notz, Michael A. Fligner
Publisher:
W. H. Freeman
Introduction to the Practice of Statistics
Statistics
ISBN:
9781319013387
Author:
David S. Moore, George P. McCabe, Bruce A. Craig
Publisher:
W. H. Freeman